Singapore-Based Global Schools Foundation Announces Strategic Partnership With Dwight School Seoul

SINGAPORE, Sept. 15, 2021 (GLOBE NEWSWIRE) — Singapore-based Global Schools Foundation has announced that it has entered into a strategic partnership with Dwight School Seoul, one of South Korea’s top international schools, popular with expatriates and locals. Dwight School Seoul is the first International Baccalaureate (IB) World School in Seoul with authorisation in all three IB Programmes for […]

Continue Reading

Singapore-Based Global Schools Foundation Announces Strategic Partnership With Dwight School Seoul

SINGAPORE, Sept. 15, 2021 (GLOBE NEWSWIRE) — Singapore-based Global Schools Foundation has announced that it has entered into a strategic partnership with Dwight School Seoul, one of South Korea’s top international schools, popular with expatriates and locals. Dwight School Seoul is the first International Baccalaureate (IB) World School in Seoul with authorisation in all three IB Programmes for […]

Continue Reading

Degreed adds embedded skills and learning analytics through strategic partnership with Visier

Deal will provide advanced analytics on skill data so Degreed clients can plan learning and development strategies to support evolving and transformative business priorities PLEASANTON, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — Workforce upskilling platform Degreed announced a strategic partnership with Visier, the globally recognized leader in people analytics and planning, to deliver business-relevant insights […]

Continue Reading

WillScot Mobile Mini Announces Closing Of Third Secondary Offering Which Completes Full Sponsor Exit

PHOENIX, Sept. 15, 2021 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a North American leader in modular space and portable storage solutions, today announced the closing of the previously announced underwritten secondary offering (the “Offering”) of 21,410,019 shares (the “Shares”) of its common stock, par value […]

Continue Reading

Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine

Toripalimab plus standard chemotherapy demonstrates improvement in PFS in first-line advanced nasopharyngeal carcinoma SHANGHAI and REDWOOD CITY, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced publication of a cover article in the September issue of Nature […]

Continue Reading